Geron
GERN
#7188
Rank
S$0.75 B
Marketcap
S$1.18
Share price
-7.86%
Change (1 day)
-16.52%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2026 (TTM): -S$24.59 Million

According to Geron's latest financial reports the company's current earnings are S$0.21 Billion. In 2025 the company made an earning of -S$65.57 Million, an increase over its 2024 earnings that were of -S$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$24.59 Million-62.5%
2025 -S$65.57 Million-67.42%
2024 -S$0.21 Billion-11.23%
2023 -S$0.23 Billion30.22%
2022 -S$0.18 Billion20.15%
2021 -S$0.15 Billion50.08%
2020 -S$96.56 Million4.46%
2019 -S$92.44 Million130.68%
2018 -S$40.08 Million8.84%
2017 -S$36.82 Million-3.08%
2016 -S$37.99 Million-22080.6%
2015 S$0.17 M-100.38%
2014 -S$45.9 Million-7.14%
2013 -S$49.43 Million
2011 -S$0.12 Billion19.04%
2010 -S$98.23 Million8.45%
2009 -S$90.58 Million-2.51%
2008 -S$92.91 Million14.65%
2007 -S$81.04 Million32.68%
2006 -S$61.08 Million25.59%
2005 -S$48.64 Million4.36%
2004 -S$46.6 Million19.73%
2003 -S$38.92 Million-15.46%
2002 -S$46.04 Million1.94%
2001 -S$45.16 Million33.59%
2000 -S$33.81 Million27.53%
1999 -S$26.51 Million63.13%
1998 -S$16.25 Million15.6%
1997 -S$14.06 Million-10.66%
1996 -S$15.74 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
-S$3.27 Billion 13,205.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
S$1.02 B-4,282.42%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-S$89.29 Million 263.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
S$0.32 B-1,414.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-S$21.31 Million-13.22%๐Ÿ‡บ๐Ÿ‡ธ USA